Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical and complex vaccines could renew the innovation engine.
Affordable biologic therapies could help expand patients’ access to treatment in the developing world. Here’s what pharma companies must know to unlock the potential.
For medtech companies, divestitures can create value. But several elements are necessary to make separations successful.
The Head of Digital Strategy and Medical Innovation, US Clinical Development and Medical Affairs at Novartis discusses how disruptive technologies and digital innovation are inspiring a start-up mind-set within the organization.